首页> 外文期刊>European Heart Journal >Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial†
【24h】

Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial†

机译:慢性氯吡格雷经皮冠状动脉介入治疗患者的氯吡格雷再负荷:ARMYDA-4 RELOAD(抗血小板疗法可减少血管成形术中心肌损伤的结果)随机试验†

获取原文
           

摘要

Aims To evaluate safety and effectiveness of clopidogrel reloading in patients on chronic clopidogrel therapy undergoing percutaneous coronary intervention (PCI).
机译:目的评估在接受经皮冠状动脉介入治疗(PCI)的慢性氯吡格雷治疗的患者中进行氯吡格雷再装载的安全性和有效性。

著录项

  • 来源
    《European Heart Journal》 |2010年第11期|p.1337-1343|共7页
  • 作者单位

    Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy;

    Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy;

    Interventional Cardiology Unit, San Filippo Neri Hospital, Rome, Italy;

    Interventional Cardiology Unit, Vito Fazzi Hospital, Lecce, Italy;

    Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy;

    Interventional Cardiology Unit, Vito Fazzi Hospital, Lecce, Italy;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号